ERBB2 and breast carcinoma: Beyond delay in diagnosis and treatment, the higher risk of metastasis and death in young women's breast cancer,41, 42, 43 and the higher proportion of hormone negative and HER2‐positive subtypes also contribute to the worse outcome of pregnancy‐associated breast cancer.13